Averywell
1 known investors
Find your way into Averywell
Sign up to see every warm intro you have to Averywell
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Averywell team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.
Investors · 1
Genesis Ventureslisted by Genesis VenturesAthens · $108K – $432K
How we know: Genesis Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seed funding roundApr 2024
Genesis Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Averywell do?
- Averywell develops a non-invasive, miRNA-based liquid blood test for early lung cancer detection and lung nodule management, using AI and machine learning to analyze microRNA profiles. The test targets both smokers and non-smokers as an at-risk screening population.
- Who are Averywell's investors?
- Averywell's investors include Genesis Ventures.

